PCI Biotech
Kristin Eivindvik is a Project Director with extensive experience in the pharmaceutical and healthcare industry. Kristin has held various positions at companies such as PCI Biotech, Alertis Medical, and Nycomed Imaging/Amersham Health/GE Healthcare. Kristin received their M.Sci.Pharm degree from the University of Oslo and attended Fagerborg Videregående Skole in Oslo.
This person is not in any offices
PCI Biotech
PCI Biotech is a biopharmaceutical company focusing on development and commercialisation of novel therapies for the treatment of cancer through its innovative photochemical internalisation (PCI) technology platform. PCI is applied to three distinct anticancer paradigms: fimaCHEM (enhancement of chemotherapeutics for localised treatment of cancer), fimaVACC (T-cell induction technology for therapeutic vaccination), and fimaNAC (nucleic acid therapeutics delivery).